Abstract
Self-care is essential in the long-term management of chronic heart failure. Heart failure guidelines stress the importance of patient education on treatment adherence, lifestyle changes, symptom monitoring and adequate response to possible deterioration. Self-care is related to medical and person-centred outcomes in patients with heart failure such as better quality of life as well as lower mortality and readmission rates. Although guidelines give general direction for self-care advice, health care professionals working with patients with heart failure need more specific recommendations. The aim of the management recommendations in this paper is to provide practical advice for health professionals delivering care to patients with heart failure. Recommendations for nutrition, physical activity, medication adherence, psychological status, sleep, leisure and travel, smoking, immunization and preventing infections, symptom monitoring, and symptom management are consistent with information from guidelines, expert consensus documents, recent evidence and expert opinion.
Original language | English |
---|---|
Journal | European Journal of Heart Failure |
Early online date | 20 Oct 2020 |
DOIs | |
Publication status | Early online date - 20 Oct 2020 |
Bibliographical note
Funding Information:: L.H. reports personal fees from Novartis, outside the submitted work. A.B.G. reports personal fees from Abbott, Novartis, Vifor Pharma, during the conduct of the study; grants from Roche Diagnostics, personal fees from Critical Diagnostics, AstraZeneca, outside the submitted work. H.P.B.L.R. reports grants and personal fees from Vifor Pharma, Novartis. J.C. reports personal fees from Novartis, Servier, Grindex, Boehringer Ingelheim, AstraZeneca; grants from Roche Diagnostics, outside the submitted work. C.M.P. reports personal fees from Novartis, Vifor Pharma, outside the submitted work. S.E.P. reports personal fees from Novartis, AstraZeneca, Vifor Pharma, outside the submitted work. J.B. reports personal fees from Novartis, BMS, Pfizer, Bayer, Servier, MSD, Boehringer Ingelheim, AstraZeneca, Abbott, Medtronic, Daichii Sankyo; grants and personal fees from Vifor, CvRX, Abiomed, Zoll, outside the submitted work. A.J.S.C. reports personal fees from AstraZeneca, Bayer, Boehringer Ingelhiem, Menarini, Novartis, Nutricia, Servier, Vifor, Actimed, Arena, Cardiac Dimensions, Corvia, CVRx, Enopace, ESN Cleer, Faraday, Gore, Impulse Dynamics, Respicardia, outside the submitted work. O.C. reports grants from Servier, Novartis, Vifor, other from Boehringer, outside the submitted work. L.H.L. reports personal fees from Merck, Sanofi, Bayer, Pharmacosmos, Abbott, Medscape, Myokardia; grants and personal fees from Vifor‐Fresenius, AstraZeneca, Relypsa, Novartis, Mundipharma, Boehringer Ingelheim; grants from Boston Scientific, outside the submitted work. M.L. reports personal fees from Vifor‐Fresenius, AstraZeneca, Relypsa, Bayer, Novartis, Boehringer Ingelheim, outside the submitted work. The other authors have nothing to disclose. Conflict of interest
Publisher Copyright:
© 2020 The Authors. European Journal of Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.
Copyright:
Copyright 2020 Elsevier B.V., All rights reserved.
Keywords
- Heart failure
- Lifestyle
- Patient education
- Self-care
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine